Pubblicazioni

A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks. DUAL VIII, a randomized trial designed to resemble clinical practice

2020 - DIABETES, OBESITY AND METABOLISM

Sesti, G.; Bardtrum, L.; Dagdelen, S.; Halladin, N.; Haluzik, M.; Orsy, P.; Rodriguez, M.; Aroda, V. R.

Liraglutide increases serum levels of microRNA-27b, -130a and -210 in patients with type 2 diabetes mellitus. a novel epigenetic effect

2020 - METABOLITES

Giglio, Rosaria Vincenza; Nikolic, Dragana; Volti, Giovanni Li; Stoian, Anca Pantea; Banerjee, Yajnavalka; Magan-Fernandez, Antonio; Castellino, Giuseppa; Patti, Angelo Maria; Chianetta, Roberta; Castracani, Carlo Castruccio; Montalto, Giuseppe; Rizvi, Ali A.; Sesti, Giorgio; Rizzo, Manfredi

One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center

2020 - ENDOCRINE PRACTICE

Maccora, C.; Ciuoli, C.; Goracci, A.; Benenati, N.; Formichi, C.; Pilli, T.; Verdino, V.; Mnutr, O. N.; Bufano, A.; Tirone, A.; Voglino, C.; Fagiolini, A.; Castagna, M. G.